MorphoSys AG To Present At Upcoming Investor Conferences Post author:Sam Post published:August 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017 Bristol-Myers Squibb Loses $4.3 Billion in Market Value After ASCO Update June 6, 2017 XW Laboratories Inc. Secures Over $17M Series B Financing Led By And September 19, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017